<DOC>
	<DOC>NCT01051817</DOC>
	<brief_summary>A randomized, multi-center, double-blind, proof-of-concept study to assess the effect of multiple infusions of AIN457 (10 mg/kg) versus placebo on disease activity as measured by MRI scans over a 24 week period in patients with relapsing-remitting multiple sclerosis</brief_summary>
	<brief_title>POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>relapsing-remitting multiple sclerosis</keyword>
	<keyword>RRMS</keyword>
</DOC>